This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Carl Zeiss Meditec AG's Median PS Value or its related term are showing as below:
LTS:0DHC'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.79 Med: 2.49 Max: 3.76
Current: 0.94
During the past 13 years, the highest Price to Median PS Value of Carl Zeiss Meditec AG was 3.76. The lowest was 0.79. And the median was 2.49.
LTS:0DHC's Price-to-Median-PS-Value is ranked worse than 60.7% of 313
companies
in the Medical Devices & Instruments industry
Industry Median: 0.78
vs LTS:0DHC: 0.94
Carl Zeiss Meditec AG Median PS Value Historical Data
The historical data trend for Carl Zeiss Meditec AG's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Carl Zeiss Meditec AG's Median PS Value
For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carl Zeiss Meditec AG's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Carl Zeiss Meditec AG's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 4.4947.
Carl Zeiss Meditec AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €23.45.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG (LTS:0DHC) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Carl Zeiss Meditec AG's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
99.225
/
105.40
=
0.94
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG Median PS Value Related Terms
Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Carl Zeiss Meditec AG (LTS:0DHC) Business Description
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0DHC has been successfully added to your 